Joe

All Photos Twitter.com
$BLU continue to be one of the best performers in 2022 After retesting the triangle's upper line is bouncing back & breaking out again the $9.36 line! The chances of Best-in-Class in RCC Chronic-Cough are high & can replace $MRK's drug if got approved!
$MDNA Duration of Treatment and Summary of Response Tumor Control Observed in 4 of 10 Evaluable Patients
$MDNA MDNA11 Preferentially Expands CD8+ T and NK Cells Over Tregs Increase in number of CD8+ T and NK cells with minimal change in Treg counts
$MDNA presentation at the "Cytokine-Based Drug Development Summit, Boston MA" just published at their website! ir.medicenna.com/static-files/6…
USD Federal Funds Rate as forecast 2.50%, and previous 1.75% twitter.com/GantosJ/status…
Let's see if the FED is gonna be a party killer again? At 2:00pm EST FOMC Statement. The Federal Funds Rate expected: 2.50%, adding 0.75% to the previous rate of 1.75% $SPY $SPX $XBI $QQQ
Looks like the Cayenne Peppers is first to ripen this year, while I'm still waiting for the Habanero peppers to grow & change color, beside the Jalapeños are almost ready. One addition to my veggie garden this year is 1 ghost pepper plant, will use 1 or 2 peppers in the mix 🥵�5h
@GantosJ Another point of emphasis is just how heavily pretreated this population of patients are - in most or all they have had 4 lines of treatment BEFORE getting MDNA11. $MDNA
Retweeted by Joe
@GantosJ yes, especially given the $mdna 11 trial population profile: "Patients enrolled in the study to date (N=14) have failed up to four lines of prior systemic therapy."
Retweeted by Joe
$MDNA data looks promising Anti-tumor Activity: 4 of 10 patients have achieved tumor control 2 patients at 10µg/kg dose (sarcoma & metastatic melanoma) 1 sarcoma at 30µg dose 1 pancreatic cancer in Cohort 4 at 60 dose 1st imaging scans in remaining 4 enrolled at 60 in Sep
$MDNA Treatment with MDNA11 leads to multi-fold increases in anti-cancer immune cells without stimulation of cells that cause immunosuppression and toxicity typically associated with native #IL2 and its ‘alpha-binding' variants.
$MDNA Data from the trial’s initial & mid-stage dose escalation cohorts showed signs of tumor control in 4 of 10 evaluable patients with hard to treat cancers such as sarcomas & pancreatic cancer that are also highly resistant to immunotherapies twitter.com/GantosJ/status…
$MDNA Medicenna Announces New Clinical Data Providing Preliminary Evidence of MDNA11’s Single Agent Anti-Cancer Activity in the Phase 1/2 ABILITY Study ir.medicenna.com/news-releases/… ir.medicenna.com/news-releases/…
$AUPH closing an open gap @ $8.54 back from 12/04/2019 hitting a New-52W-Low of $8.43 today after the patent news! Is it a BTFD opportunity? Prefer to wait for the 3-days rule to pass!
$CRDL is moving up >7% while large volume flowing in as we can see in the 5min itraday chart
$PINK.V$PYNKF continue working nonstop to educate the medical teams how the FDA cleared S-Series can help the surgeon & the #BreastCancer patient in real-time during the surgery. twitter.com/PerimeterMed/s…
$CRDL bouncing back from the triangle's lower line & the stochastics is out from the Over-Sold territory! Next is the old $1.48 resistance line & the triangle's upper line! Waiting for the #Myocarditis Ph2 trial updates!
Many asked me for $TLRY chart analysis! $TLRY is breaking out the 50MA (but we need a closing above it as well) with positive momentum... Next level is the weekly line $4.41 if breaks, then will be fast to test the downtrend line (light blue) & 200MA around $6.5's
$PNPN Power Nickel releases initial NI 43-101 resource for Nisk project in Québec showing over 2.5M indicated tonnes at 1.20% nickel-equivalent tinyurl.com/26crv8oz #PNPN
Retweeted by Joe
$MDNA breaking out the 200MA in preparation for the next data release 07/27 🟢Expect updated PK/PD data from cohort 4 at Cytokine Summit July 27 at 12pm 🟢1st follow-up CT scans at the higher dose cohort 4 in Q3 🟢Full set of efficacy data for all dose escalation cohorts in HHj
Twiends™ uses the Twitter™ API, displays it's logo & trademarks, and is not endorsed or certified by them. These items remain the property of Twitter. We do not sell followers, we only provide display advertising. Bots & fake accounts are not permitted on twiends. © 2009
Grow Your Twitter Free
Want To Grow Your Twitter?
We help other people find and follow you on Twitter.
Key Info:
Started in 2009
Over 6 million signups
Country targeting provided
We never auto tweet to your timeline
We never auto follow others
We actively moderate our community
Please Share
Please upgrade your browser  chrome